Karen McCoy
Nationwide Children's Hospital(US)The Ohio State University(US)Nationwide Mutual Insurance Company (United States)(US)
Publications by Year
Research Areas
Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, Asthma and respiratory diseases, Tracheal and airway disorders, Inhalation and Respiratory Drug Delivery
Most-Cited Works
- → Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR(2015)1,609 cited
- → Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial(2019)1,322 cited
- → Longitudinal Assessment ofPseudomonas aeruginosain Young Children with Cystic Fibrosis(2001)557 cited
- → Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation(2011)494 cited
- → Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis*(2001)395 cited
- → Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis